Books on the topic 'Drug selection'

Scotti, Marcus T., and Carolina L. Bellera, eds. Drug Target Selection and Validation. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-95895-4.

Trottet, Lionel, and Howard Maibach, MD. Dermal Drug Selection and Development. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59504-7.

Meeting, World Health Organization Expert Committee on the Selection and Use of Essential Medicines. The selection and use of essential medicines. Geneva: World Health Organization, 2003.

WHO Expert Committee on the Selection and Use of Essential Medicines. The selection and use of essential medicines. Geneva: World Health Organization, 2004.

Patrick, Augustijns, and Brewster Marcus, eds. Solvent systems and their selection in pharmaceutics and biopharmaceutics. New York, NY: Springer, 2007.

Masson, Alison. Generic substitution and prescription drug prices: Economic effects of state drug product selection laws. [Washington, D.C.?]: Bureau of Economics, Federal Trade Commission, 1985.

Simons, David R. Hypertension: A physician's guide to drug selection and use. Boulder, Colo. (1550 Baseline Rd., Boulder 80302): Keyed Reviews Publications, 1986.

Venitz, J., and W. Sittner, eds. Appropriate Dose Selection — How to Optimize Clinical Drug Development. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-49529-1.

Parmeter, John E. Guide for the selection of drug detectors for law enforcement applications. Washington, DC: U.S. Dept. of Justice, Office of Justice Programs, National Institute of Justice, 2000.

W, Murray Dale, Hannum D. W, National Institute of Standards and Technology (U.S.). Office of Law Enforcement Standards., National Institute of Justice (U.S.). Office of Science and Technology., and Law Enforcement and Corrections Standards and Testing Program (U.S.), eds. Guide for the selection of drug detectors for law enforcement applications. Washington, DC: U.S. Dept. of Justice, Office of Justice Programs, National Institute of Justice, 2000.

1957-, Gibson Mark, ed. Pharmaceutical preformulation and formulation: A practical guide from candidate drug selection to commercial dosage form. Englewood, CO: Interpharm Press, 2001.

World Health Organization (WHO). The Selection and Use of Essential Medicines: Report of the WHO Expert Committee 2007. Geneva: World Health Organization, 2008.

Pauly, Mark V. Adverse selection and the challenges to stand-alone prescription drug insurance. Cambridge, Mass: National Bureau of Economic Research, 2003.

D, Quick Jonathan, Management Sciences for Health (Firm), and Action Programme on Essential Drugs and Vaccines (World Health Organization), eds. Managing drug supply: The selection, procurement, distribution, and use of pharmaceuticals. 2nd ed. West Hartford, Conn., USA: Kumarian Press, 1997.

Ahn, Hyewon. Patentability of chemical selection inventions: The Olanzapine and Escitalopram decisions. Baden-Baden: Nomos, 2011.

The selection and use of essential medicines: Report of the WHO Expert Committee, 2009, (including the 16th model list of essential medicines and the 2nd WHO model list of essential medicines for children). Geneva: World Health Organization, 2009.

Organization, World Health, ed. The selection and use of essential medicines: Report of the WHO Expert Committee 2015, (including the 19th WHO Model List of Essential Medicines and the 5th WHO Model List of Essential Medicines for Children). Geneva, Switzerland: World Health Organization, 2015.

Nebraska. 1989 state of Nebraska statutes, rules, and regulations relating to, pharmacy ; Nebraska Drug Product Selection Act. Lincoln, Neb: Dept. of Health, Bureau of Examining Boards, 1989.

WHO Expert Committee on the Selection and Use of Essential Medicines. The selection and use of essential medicines: Report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children). Geneva, Switzerland: World Health Organization, 2014.

Lefevre, Ethan C. Food labelling: The FDA's role in the selection of healthy foods. New York: Nova Science Publishers, 2009.

Food labelling: The FDA's role in the selection of healthy foods. New York: Nova Science Publishers, 2009.

Fishman, Marc. ASAM patient placement criteria: Supplement on pharmacotherapies for alcohol use disorders. Edited by American Society of Addiction Medicine. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2010.

Casey, Verna. The screening of employees: A selected bibliography. Monticello, Ill., USA: Vance Bibliographies, 1988.

United States. Congress. Senate. Committee on the Judiciary. Mr. Robert Martinez to be director of National Drug Control Policy: Report together with supplemental, additional and minority views (to accompany the nomination of Mr. Bob Martinez to be director of National Drug Control Policy). [Washington, D.C.?: U.S. G.P.O., 1991.

Office, General Accounting. Drug war: Drug Enforcement Administration staffing and reporting in Southeast Asia : report to the Chairman and Ranking Minority Member, Committee on Government Operations, House of Representatives. Washington, D.C: U.S. General Accounting Office, 1992.

United States. Congress. Senate. Committee on the Judiciary. Nomination of Robert Martinez to be director of the Office of National Drug Control Policy (drug czar): Hearings before the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session ... February 26 and 27, 1991. Washington: U.S. G.P.O., 1992.

Office, General Accounting. Drug war: Observations on counternarcotics aid to Colombia : report to Congressional requesters. Washington, D.C: U.S. General Accounting Office, 1991.

Williamson, Elizabeth M. Selection, preparation, and pharmacological evaluation of plant material. Chichester: J. Wiley, 1996.

United States. Congress. Senate. Committee on the Judiciary. Confirmation hearing on the nomination of Asa Hutchinson to be Administrator of the Drug Enforcement Administration: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Seventh Congress, first session, July 17, 2001. Washington: U.S. G.P.O., 2002.

United Nations Dag Hammarskjold Library. Selective bibliography on drug abuse, drug traffic and drug control. [Geneva]: the Library, 1990.

Office, General Accounting. The drug war: U.S. programs in Peru face serious obstacles : report to congressional requesters. Washington, D.C: The Office, 1991.

Office, General Accounting. The drug war: U.S. programs in Peru face serious obstacles : report to Congressional requesters. Washington, D.C: U.S. General Accounting Office, 1991.

United States. Congress. Senate. Committee on the Judiciary. Dr. William J. Bennett to be Director of National Drug Control Policy: Report together with additional and minority views (to accompany the nomination ...). [Washington, D.C.?: U.S. G.P.O., 1989.

United States. Congress. Senate. Committee on the Judiciary. Dr. William J. Bennett to be Director of National Drug Control Policy: Report together with additional and minority views (to accompany the nomination ...). [Washington, D.C.?: U.S. G.P.O., 1989.

Judiciary, United States Congress Senate Committee on the. Dr. William J. Bennett to be Director of National Drug Control Policy: Report together with additional and minority views (to accompany the nomination ...). [Washington, D.C.?: U.S. G.P.O., 1989.

Selective toxicity: The physico-chemical basis of therapy. 7th ed. London: Chapman and Hall, 1985.

United States. Congress. Senate. Committee on the Judiciary. Nominations of Robert S. Warshaw, to be Associate Director, and Thomas J. Umberg to be Deputy Director for Supply Reduction: Hearing before the Committee on the Judiciary, One Hundred Fifth Congress, first session ... both of the Office of National Drug Control Policy, November 6, 1997. Washington: U.S. G.P.O., 1998.

United States. Congress. Senate. Committee on the Judiciary. Confirmation hearing on the nomination of John P. Walters to be Director of the Office of National Drug Control Policy: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Seventh Congress, first session, October 10, 2001. Washington: U.S. G.P.O., 2002.

Reinhard, Sittl, and Budd Keith, eds. Practice of transdermal pain therapy. Bremen: Uni-Med, 2005.

United States. Congress. Senate. Committee on the Judiciary. Nomination of Barry R. McCaffrey to be Director of the National Drug Control Policy: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session ... February 27, 1996. Washington: U.S. G.P.O., 1997.

United States. Congress. Senate. Committee on the Judiciary. Executive branch nominations: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Seventh Congress, second session, March 5, 2002. Washington: U.S. G.P.O., 2003.

United States. Congress. Senate. Committee on the Judiciary. Confirmation hearings of federal appointments to the Office of National Drug Control Policy (Bennett, Walton, and Morris): Hearings before the Committee on the Judiciary, United States Senate, One Hundred First Congress, first session ... March 1, 2, June 6, and September 20, 1989. Washington: U.S. G.P.O., 1991.

United States. Congress. Senate. Committee on the Judiciary. Confirmation hearings of federal appointments to the Office of National Drug Control Policy (Bennett, Walton, and Morris): Hearings before the Committee on the Judiciary, United States Senate, One Hundred First Congress, first session, on the nominations of Dr. William J. Bennett to be Director ..., Reggie B. Walton to be Associate Director, and Stanley E. Morris to be Deputy Director ... March 1, 2, June 6, and September 20, 1989. Washington: U.S. G.P.O., 1991.

United States. Congress. Senate. Committee on the Judiciary. Confirmation hearings of federal appointments to the Office of National Drug Control Policy (Bennett, Walton, and Morris): Hearings before the Committee on the Judiciary, United States Senate, One Hundred First Congress, first session, on the nominations of Dr. William J. Bennett to be Director ..., Reggie B. Walton to be Associate Director, and Stanley E. Morris to be Deputy Director ... March 1, 2, June 6, and September 20, 1989. Washington: U.S. G.P.O., 1991.

United States. Congress. Senate. Committee on the Judiciary. Nomination of Lee Patrick Brown: Hearing before the Committee on the Judiciary, United States Senate, One Hundred Third Congress, first session, on the nomination of Lee Patrick Brown, to be Director of the Office of National Drug Control Policy, May 25, 1993. Washington: U.S. G.P.O., 1994.

United States. Congress. House. Committee on Government Operations. Government Information, Justice, and Agriculture Subcommittee. INS technology selection: Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 12, 1988. Washington: U.S. G.P.O., 1988.

United, States Congress House Committee on Government Operations Government Information Justice and Agriculture Subcommittee. INS technology selection: Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 12, 1988. Washington: U.S. G.P.O., 1988.

United States. Congress. House. Committee on Government Operations. Government Information, Justice, and Agriculture Subcommittee. INS technology selection: Hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 12, 1988. Washington: U.S. G.P.O., 1988.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment. Senate confirmation of the FDA commissioner; and reauthorization of research activities by ADAMHA: Hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 3909 ... March 6, 1986. Washington: U.S. G.P.O., 1986.

E, Adams Gerald, and North Atlantic Treaty Organization. Scientific Affairs Division., eds. Selective activation of drugs by redox processes. New York: Plenum Press, 1990.